Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Mød ledelsen i Gubra og stil spørgsmål til dagens investorpræsentation

By Philip CoombesEquity Research Analyst
Gubra

I dag kl. 13:00 vil Gubra CFO Kristian Borbos og IR and Strategy Lead Emma Jappe Lange præsentere årsregnskabet for 2025 og svare på spørgsmål fra publikum. Tilmeld dig og stil dine spørgsmål allerede nu: https://www.inderes.dk/videos/gubra-praesentation-af-arsregnskabet-for-2025

Disclaimer: HC Andersen Capital modtager betaling fra det nævnte selskab for en digital IR abonnementsaftale. /Philip Coombes d. 03/03-2026 kl. 08:30.

Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They primarily conduct research and development in the area of metabolic and fibrotic diseases. The company's product portfolio includes several brands and drugs, and the operations are conducted on a global level, with the largest presence in North America and the Nordic region. The headquarters are located in Hørsholm, Denmark.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.